GINKGO BIOWORKS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 05 Apr 2026 08:52:21 +0200https://images.finanzen.net/images/finanzen_net_neu.gifGINKGO BIOWORKS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netGinkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening ApproachMon, 22 Dec 2025 19:21:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-with-carnegie-mellon-university-to-develop-innovative-new-cancer-screening-approach-15375440

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-with-carnegie-mellon-university-to-develop-innovative-new-cancer-screening-approach-15375440Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil AmendmentWed, 17 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-and-agricen-enter-collaboration-to-optimize-manufacturing-processes-for-a-key-agricultural-soil-amendment-15364919

Collaboration reduces time in fermenting complex bacterial strains, enabling continued focus on next-gen biological crop solutions.

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-and-agricen-enter-collaboration-to-optimize-manufacturing-processes-for-a-key-agricultural-soil-amendment-15364919Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safetyTue, 09 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-on-deep-origin-led-team-to-develop-new-tools-for-predicting-drug-safety-15345640

BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-on-deep-origin-led-team-to-develop-new-tools-for-predicting-drug-safety-15345640Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PCFri, 05 Dec 2025 14:33:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-selected-by-pnnl-to-deliver-a-modular-high-throughput-phenotyping-platform-for-doe-s-m2pc-15338572

BOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-selected-by-pnnl-to-deliver-a-modular-high-throughput-phenotyping-platform-for-doe-s-m2pc-15338572STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene TherapyWed, 03 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/strm-bio-awarded-arpa-h-contract-to-advance-megakaryocyte-derived-vesicle-platform-for-in-vivo-cell-engineering-and-gene-therapy-15331847

CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral ...

]]>https://www.finanzen.net/nachricht/aktien/strm-bio-awarded-arpa-h-contract-to-advance-megakaryocyte-derived-vesicle-platform-for-in-vivo-cell-engineering-and-gene-therapy-15331847Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral HealthTue, 18 Nov 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-on-illinois-led-team-to-develop-innovative-new-treatments-for-oral-health-15287794

BOSTON, Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-partners-on-illinois-led-team-to-develop-innovative-new-treatments-for-oral-health-15287794Ginkgo Bioworks Reports Third Quarter 2025 Financial ResultsThu, 06 Nov 2025 22:05:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-reports-third-quarter-2025-financial-results-15212140

Ginkgo provides an update on its third quarter financial results

BOSTON, ]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-reports-third-quarter-2025-financial-results-15212140Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-ConsortiumMon, 03 Nov 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-awarded-project-agreement-through-barda-s-biomap-consortium-15176147

Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-awarded-project-agreement-through-barda-s-biomap-consortium-15176147Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for AgricultureFri, 31 Oct 2025 13:00:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-and-bayer-extend-multi-year-strategic-partnership-to-accelerate-next-generation-biological-solutions-for-agriculture-15156064

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-and-bayer-extend-multi-year-strategic-partnership-to-accelerate-next-generation-biological-solutions-for-agriculture-15156064Ginkgo Bioworks Announces Date of Third Quarter 2025 Results PresentationThu, 30 Oct 2025 21:05:00 +0100https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-announces-date-of-third-quarter-2025-results-presentation-15150963

Presentation and Q&A session scheduled for post-market on Thursday, November 6, 2025

BOSTON, ...

]]>https://www.finanzen.net/nachricht/aktien/ginkgo-bioworks-announces-date-of-third-quarter-2025-results-presentation-15150963